Oragenics Inc. (OGEN)
NYSE: OGEN · Pharmaceutical Preparations · Lakewood Ranch, FL · filing with the SEC since 2002
Who owns Oragenics Inc.
As filed with the SECHolders of 5% or more
2
Five Narrow Lane LP holds 9.99% of COMMON STOCK, $0.001 PAR VALUE PER SHARE, as its SCHEDULE 13G filed Jul 2, 2025 says.
Directors and officers
8
report now, of 15 people on the record since 2009. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Five Narrow Lane LP
SCHEDULE 13G · filed Jul 2, 2025 · COMMON STOCK, $0.001 PAR VALUE PER SHARE
Sabby Management, LLC
SCHEDULE 13G · filed Jan 21, 2026 · Common Stock
What OGEN reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Dawson James Securities Inc
An entity · legal entity · owns, named in the 10-K filed Mar 16, 2026
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 16, 2026.
Insider tradesForm 4
2sales
0purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 21 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Telling Fred | director | 2 | $0 | 0 | 0 | $0 |